TEMPE, Ariz.--(BUSINESS WIRE)--Kinetic Muscles Inc. (“KMI”, www.kineticmuscles.com), a leading innovator of neurorehabilitation technology, announced it has received a 2-year Phase II SBIR grant to study a new treatment for veterans returning from active duty with traumatic brain injury (TBI).
